Dexcom (DXCM) |
|
411 15.205 (3.84%)
|
10-24 14:01 |
|
Open: |
398 |
Pre. Close: |
395.795 |
|
High:
|
411.205 |
Low:
|
396.965 |
|
Volume:
|
534,976 |
Market Cap:
|
39,350M |
|
|
|
|
DexCom, Inc. is a medical device manufacturing company. The company is headquartered in San Diego, California and currently employs 2,800 full-time employees. The firm is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The firm's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The firm is commercializing its fifth generation CGM system. The firm's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers). |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
411.899 - 413.867 |
413.867 - 415.653 |
|
Low:
|
392.129 - 394.412 |
394.412 - 396.484 |
|
Close:
|
407.178 - 410.991 |
410.991 - 414.452 |
|
Technical analysis |
as of: 2020-10-23 4:42:55 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 490.56 One year: 572.97 |
| Support: |
Support1: 391.21 Support2: 373.41 |
| Resistance: |
Resistance1: 420.00 Resistance2: 490.56 |
| Pivot: |
393.53 |
| Moving Average: |
MA(5): 396.91 MA(20): 395.80
MA(100): 408.22 MA(250): 321.97 |
| MACD: |
MACD(12,26): -0.54 Signal(9): -2.38 |
| Stochastic oscillator: |
%K(14,3): 55.17 %D(3): 45.67 |
| RSI: |
RSI(14): 56.26 |
| 52-week: |
High: 456.23 Low: 149.46 Change(%): 171.1 |
| Average Vol(K): |
3-Month: 75527 10-Days: 74927 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.DXCM has closed below upper band by 0.0%. Bollinger Bands are 28.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sat, 24 Oct 2020
Why buying the DexCom, Inc. (NASDAQ:DXCM) Stock Today Might Make Sense - Stocks Register
Fri, 23 Oct 2020
Is This The Calm Before The Storm On DexCom, Inc. (DXCM)? - Invest Million
Fri, 23 Oct 2020
Teladoc and DexCom: 2 stocks that are better buys than Apple - USA TODAY
Wed, 21 Oct 2020
DexCom (DXCM) Dips More Than Broader Markets: What You Should Know - Yahoo Finance
Wed, 21 Oct 2020
Were Hedge Funds Right About DexCom, Inc. (DXCM)? - Yahoo Finance
Wed, 21 Oct 2020
DexCom (DXCM) to Report Q3 Earnings: What's in the Cards? - Yahoo Finance
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
96 |
| Shares Float (M) |
95 |
|
% Held by Insiders
|
0.44 |
|
% Held by Institutions
|
100.53 |
|
Shares Short (K)
|
3,820 |
|
Shares Short P. Month (K)
|
3,800 |
Stock Financials |
|
EPS
|
2.160 |
|
EPS Est This Year
|
-0.800 |
|
EPS Est Next Year
|
-0.430 |
|
Book Value (p.s.)
|
14.190 |
|
Profit Margin
|
11.93 |
|
Operating Margin
|
16.03 |
|
Return on Assets (ttm)
|
6.2 |
|
Return on Equity (ttm)
|
20.0 |
|
Qtrly Rev. Growth
|
34.3 |
|
Gross Profit (p.s.)
|
9.729 |
|
Sales Per Share
|
17.965 |
|
EBITDA (p.s.)
|
3.267 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
394 |
|
Levered Free Cash Flow (M)
|
48 |
Stock Valuations |
|
PE Ratio
|
190.28 |
|
PEG Ratio
|
2.01 |
|
Price to Book value
|
28.96 |
|
Price to Sales
|
22.88 |
|
Price to Cash Flow
|
99.82 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
